ARTICLE | Preclinical News
Summit identifies two new classes of antibiotics
June 11, 2018 11:12 PM UTC
Summit Therapeutics plc (LSE:SUMM; NASDAQ:SMMT) identified two new types of narrow-spectrum antibiotics targeting new Neisseria gonorrhoeae targets that could help treat gonorrhea.
Summit presented its findings at the American Society for Microbiology Microbe (ASM Microbe) conference in Atlanta...